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In vascular smooth muscle cells (VSMC) increased integrin adhesion to extracellular matrix
(ECM) proteins, as well as the production of reactive oxygen species (ROS) are strongly
stimulated by lysophosphatidic acid (LPA). We hypothesized that LPA-induced generation
of ROS increases integrin adhesion to the ECM. Using atomic force microscopy (AFM)
we determined the effects of LPA on integrin adhesion to fibronectin (FN) in VSMC
isolated from rat (Sprague–Dawley) skeletal muscle arterioles. In VSMC, exposure to LPA
(2μM) doubled integrin-FN adhesion compared to control cells (P < 0.05). LPA-induced
integrin-FN adhesion was reduced by pre-incubation with antibodies against β1 and β3
integrins (50μg/ml) by 66% (P < 0.05). Inhibition of LPA signaling via blockade of the
LPA G-protein coupled receptors LPAR1 and LPAR3 with 10μM Ki16425 reduced the
LPA-enhanced adhesion of VSCM to FN by 40% (P < 0.05). Suppression of ROS with
tempol (250μM) or apocynin (300μM) also reduced the LPA-induced FN adhesion by 47%
(P < 0.05) and 59% (P < 0.05), respectively. Using confocal microscopy, we observed that
blockade of LPA signaling, with Ki16425, reduced ROS by 45% (P < 0.05), to levels similar
to control VSMC unexposed to LPA. In intact isolated arterioles, LPA (2μM) exposure
augmented the myogenic constriction response to step increases in intraluminal pressure
(between 40 and 100mm Hg) by 71% (P < 0.05). The blockade of LPA signaling, with
Ki16425, decreased the LPA-enhancedmyogenic constriction by 58% (P < 0.05). Similarly,
blockade of LPA-induced ROS release with tempol or gp91 ds-tat decreased the LPA-
enhanced myogenic constriction by 56% (P < 0.05) and 55% (P < 0.05), respectively.
These results indicate that, in VSMC, LPA-induced integrin activation involves the G-
protein coupled receptors LPAR1 and LPAR3, and the production of ROS, and that LPA
may play an important role in the control of myogenic behavior in resistance vessels
through ROS modulation of integrin activity.
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INTRODUCTION
Integrin activation and signaling are indispensible for cell sur-
vival, proliferation and motility under physiological and patho-
logical conditions. Recently, increased integrin adhesion has been
associated with aging and hypertension (Zhu et al., 2012; Sehgel
et al., 2013). Integrins are heterodimeric cell surface receptors
composed of one α and one β subunit that are non-covalently
associated. Their N-terminal domains mediate attachment to the
extracellular matrix (ECM), while their intracellular domains
attach to a series of scaffolding proteins that ultimate connect
Abbreviations: VSMC, vascular smooth muscle cell; ECM, extracellular matrix;
ROS, reactive oxygen species; LPA, lysophosphatidic acid; LPAR, lysophosphatidic
acid receptor; AFM, atomic force microscopy; TGF-β, transforming growth factor-
β; NADPH, nicotinamide adenine dinucleotide phosphate; PSS, physiological
saline solution; DHE, dihydroethidium.
to the cytoskeleton (Martinez-Lemus et al., 2003). Integrins do
not possess enzymatic activity, but many of the scaffolding pro-
teins that attach to their intracellular domains do. This allows
integrins to transmit signals from the ECM to the cytoskeleton
(outside-in) and vice versa (inside-out), making them particu-
larly suited to participate in the mechanotransduction of sig-
nals across the plasma membrane of many cell types (Wilson
et al., 1995; Goldschmidt et al., 2001; Balasubramanian et al.,
2007; Delon and Brown, 2007; Hong et al., 2012). In vascular
smooth muscle cells (VSMC), integrin activity has been associ-
ated with a number of physiological and pathological processes
including the modulation of myogenic phenomena and vascu-
lar remodeling (Martinez-Lemus et al., 2005a; Heerkens et al.,
2006). In particular, integrins have been postulated to serve as
mechanosensors able to convert changes in physical parameters
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such as ECM tension and cellular stress into chemical sig-
nals that modulate vascular diameter (Martinez-Lemus et al.,
2005b). Previously, we have shown that αvβ3 and α5β1 inte-
grin blockade inhibits the myogenic vasoconstriction associated
with increments in intravascular pressure in isolated arterioles
(Martinez-Lemus et al., 2005a).We also showed that in rat VSMC,
lysophosphatidic acid (LPA) increases integrin fibronectin (FN)
adhesion, suggesting that LPA modulates integrin activation (Sun
et al., 2005). Additionally, transforming growth factor-β acti-
vation, associated with airway remodeling in severe asthma, is
induced by exposure to LPA and is preceded by integrin activa-
tion (Tatler et al., 2011). These studies in isolated arterioles and
smoothmuscle cells (SMC) clearly indicate thatmechanical forces
and LPA modulate integrin activity. However, the exact mecha-
nisms by which mechanical forces and in particular LPA induce
integrin activation are not completely known.
LPA is a small phospholipid with a wide array of biological
functions such as, cell proliferation and survival, platelet aggre-
gation, cell migration, and SMC contraction (Cheng et al., 2009;
Cui, 2011; Gaaya et al., 2012; Nam et al., 2013). The biological
effects of LPA are mediated through specific G-protein coupled
cell surface receptors named LPAR1-6 (Choi et al., 2010; Yanagida
and Ishii, 2011) and through intracellular receptors such as the
peroxisome proliferator-activated receptor-γ (Cheng et al., 2009).
In vivo, administration of LPA results in acute increases in blood
pressure in different animal species (Tokumura et al., 1985, 1995),
suggesting a role for LPA in both normal blood pressure regula-
tion and hypertension. Furthermore, LPA mediated signaling has
been shown to be involved in neointimal proliferation (Cheng
et al., 2009), vascular remodeling (Yoshida et al., 2003), and
angiogenesis (Sumida et al., 2010). Recent studies also indicate
that, in VSMC, LPA is responsible for the generation of reac-
tive oxygen species (ROS). In one study, the mitogenic effects of
LPA were diminished by the inhibition of nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase (Schmitz et al., 2002).
Similarly, LPA induced proliferation of human aortic VSMC is
dependent on the activity of Rac-1 and is blocked by treatment
with antioxidants or inhibition of NADPH oxidase (Kaneyuki
et al., 2007). These studies indicate that LPA-stimulation of cells
results in increased ROS production. Therefore, we designed this
study to test the hypothesis that, in VSMC, LPA activates inte-
grins and increases integrin-FN adhesion through pathways that
depend on the production of ROS. As mentioned above, we
have previously shown that integrins are involved in the myo-
genic response (Martinez-Lemus et al., 2005a). Recently, myo-
genic vasoconstriction as it occurs in response to increments
in intraluminal pressure in resistance arteries has been associ-
ated with the production of ROS by cells within the vascular
wall (Gebremedhin et al., 2013). Therefore, we also tested the
effects of LPA on myogenic reactivity in isolated resistance vessels
expecting that myogenic vasoconstriction would be enhanced via
LPA-dependent production of ROS.
MATERIALS AND METHODS
ANIMAL MODEL
All procedures involving animals complied with the NIH Guide
for the Care and Use of Laboratory Animals, and were approved
by the Animal Care and Use committee of the University of
Missouri-Columbia. Male Sprague-Dawley rats (180–250 g) were
anesthetized by an intraperitoneal injection with 100mg/Kg pen-
tobarbital sodium. Following anesthesia, the cremaster muscle
was excised through a scrotal incision. After excision of the
tissue, the rat was euthanized by bilateral pneumothorax and
exsanguination.
VSMC ISOLATION AND CULTURE
VSMC were enzymatically isolated from first-order cremas-
teric arterioles using previously described methods (Sun et al.,
2008). Briefly, VSMC were isolated from first order cremasteric
arterioles via enzymatic digestions with papain, collagenase,
and elastase. The isolated VSMC were maintained in cul-
ture conditions in DMEM/F-12 media (Invitrogen, Carlsbad,
CA) supplemented with 10% fetal bovine serum (FBS, Atlanta
Biologicals, Lawrenceville, GA), 100μg/mL streptomycin, 100
U/mL penicillin, 2mM L-glutamine, 1mM sodium pyruvate,
and 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES, Sigma, St Louis, MO, USA). Cells were plated on 60mm
tissue culture dishes (Falcon, BD Labware, Lincoln, NJ) and kept
in a humidified incubator (Heraeus Instruments, Newtown, CT)
with 5% CO2 at 37◦C. In all experiments cells at passages 3–13
were used. Except were otherwise indicated, the above reagents
and chemicals were purchased from Invitrogen.
INTEGRIN ADHESION ASSAYS
All adhesion assays were performed using an MFP-3D atomic
force microscopy (AFM) system (Asylum Research, Santa
Barbara, CA) mounted on an inverted Olympus IX81 optical
microscope. Data was collected using Igor Pro 6.0 (WaveMetrics,
Lake Oswego, OR) and analyzed using a software package written
in Matlab (MathWorks, Natick, MA) (Sun et al., 2005). All AFM
probes were functionalized with FN. For this purpose, a spher-
ical 5μm borosilicate micro bead (Spi Supplies, West Chester,
PA, USA) was attached to a triangular silicon-nitride AFM probe
(Veeco-MLCT 010, spring constant = 30 pN/nm) using epoxy
glue. Subsequently, the AFM probe was functionalized with FN
(Invitrogen, Carlsbad, CA) as we have previously described (Qiu
et al., 2010; Hong et al., 2012). Briefly, 10mM polyethylene glycol
(Sigma, St. Louis, MO) was used as a non-covalent linker to facili-
tate the passive absorption of FN onto the borosilicate glass micro
bead. The probe was first incubated 5min with polyethylene gly-
col, washed 3 times with phosphate buffered saline, and then
incubated 5min with FN (0.2mg/ml). Following the FN incuba-
tion, the AFM probe was washed 3 times with phosphate buffered
saline. Calibration experiments revealed that the functionaliza-
tion procedure did not significantly alter the spring constant of
the AFM probe.
Real-time monitoring of the FN coated bead adhesive prop-
erties on VSMC was performed with the AFM in force mode by
repeated nanoindentation (black curve, Figures 1A,B) and retrac-
tion (gray curve, Figures 1A,B) from the cell surface at a 0.5Hz
sampling frequency, ∼800 nm/s scanning speed, and 800 nm
force distance. For each experiment, cells were randomly selected
and probed at sites located 1/3–1/2 the distance between the cell
margin and the nucleus. One hundred force curves for each cell
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FIGURE 1 | LPA increases the adhesion between FN and integrins
containing β1 and β3 subunits. (A–B) Typical force curves obtained
during AFM adhesion experiments. The black line represents the
cantilever approach curve, while the gray one represents the retraction
curve. The numbers on gray curves represent adhesion events detected
as sharp vertical jumps in the retraction curve. (A) Force curve with no
adhesion events. (B) Force curve with 2 adhesion events (1, 2). Force
adhesion events distribution for control (C) and LPA treated cells (D).
The number of single adhesion events (first peak) in the LPA treated
cells (D) increases significantly above the control level (C). The adhesion
force is not changed by LPA treatment. (E) VSMC adhesion to FN is
reduced significantly, by 52%, in untreated (control) cells (n = 40)
compared to LPA treated cells (n = 40). (F) The incubation of VSMC with
LPA (2μM) in the presence of β1 and β3 (50μg/ml) antibodies (n = 40)
resulted in a 66% decrease in the number of adhesion events per curve
compared to VSMC treated with LPA alone (n = 40). (G) Compared with
the VSMC treated with LPA alone (n = 40), LPA treatment (2μM) in the
presence of isogroup control antibody (50μg/ml), does not significantly
change the number of adhesion events per curve (n = 38). Data are
means ± s.e.m. ∗P < 0.05 vs. LPA (E,F).
were collected over a period of ∼3.5min up to a maximum of 10
cells per dish. During retraction of the AFM probe, the lack of
adhesion events results in the retraction curve closely following
the approach curve without abrupt changes in the force required
to pull the cantilever away from the cell (Figure 1A). Alternatively,
the presence of adhesion events is detected as sharp vertical shifts
in the retraction curve (Sun et al., 2005) (Figure 1B). The num-
ber of adhesions per curve was quantified as the total number of
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unbinding (adhesion) events detected for one cell, divided by the
total number of force-curves recorded for the same cell. All the
AFM experiments were performed at room temperature. To min-
imize the effects of drift, the systemwas equilibratedmechanically
and thermally for at least 30min with the probe submerged in
serum-free media. For each experiment the same probe was used
on control and treated cells. The sampling order was randomized
between controls and treatments.
To determine the effect of LPA on the adhesion of FN to
VSMC integrins, cells were exposed to LPA (2μM) in serum free
DMEM/F-12 media for 2 h at 37◦C in 5% CO2. Subsequently,
cells were transferred to the AFM and the adhesion properties
were determined as described above. Control cells were exposed
to serum free media in the absence of LPA. Exposure to LPA was
maintained for the duration of the AFM experiments.
To determine if the effect of LPA on adhesion events occurred
via LPA signaling through VSMC membrane bound G-protein
coupled receptors, LPA receptors (LPAR) were blocked with
Ki16425 (10μM). Ki16425 (Selleckchem, Houston, TX) was
added to the cells 30min before and throughout the exposure of
cells to LPA. Control cells for this series of experiments did not
receive Ki16425, but were exposed to LPA (2μM) as described
above.
To corroborate that the changes in VSMC adhesion to the
FN coated bead was mediated by integrins, specific function-
blocking monoclonal antibodies against β1 (50μg/mL, Ha 2/5)
and β3 (50μg/mL, F11) integrins were used. The antibodies were
added simultaneously to the cell bath 30min before the AFM
experiments were performed while the VSMC were incubated in
serum free media in the presence of LPA (2μM). Control cells
were exposed to an isotype control antibody (50μg/mL, G235-1).
Additional control experiments were performed in parallel with-
out antibodies in the presence of LPA (2μM). All antibodies were
purchased from BD Pharmingen (San Jose, CA).
To determine the role of ROS on the changes in integrin
to FN adhesion induced by LPA, AFM experiments were per-
formed in the presence of the superoxide dismutase mimetic,
tempol or the NADPH oxidase inhibitor, apocynin (Calbiochem,
Billerica, MA). Tempol (250μM), apocynin (300μM) or DMSO
(5mg/ml), were added to the cells 30min before and throughout
the 2-hour exposure to LPA. Additional control experiments were
performed in parallel without LPA.
ROS DETECTION ASSAY
To corroborate that LPA increases the production of ROS
in VSMC, we used the ROS-sensitive fluorescent probe dihy-
droethidium (DHE) to assess the presence of intracellular ROS.
In these experiments, VSMC plated in glass bottom dishes (Wilco
Wells, Amsterdam, Netherlands) were incubated in serum free
media for 2 h in the presence or absence (control) of LPA (2μM).
DHE (10μM) was applied to the serum free media concurrently
with LPA or its vehicle control. After the application of DHE,
the cells were imaged with a confocal microscope (Leica TCS
SP5) using a 40X oil-immersion objective (numerical aperture
1.25). During imaging, the cells were kept at room temperature
as in the AFM experiments. Images obtained after 2 h of incuba-
tion with LPA or vehicle control were compared for fluorescence
intensity. All images were obtained with exactly the same param-
eter settings: excitation wavelength 514 nm, emission detection
wavelength range 600–700 nm, and detector gain of 600. A total
of 42 z-sections were acquired at 0.5μm intervals covering the
complete height of the cells. The mid cell section was used for
image analysis. A Matlab script was used to analyze the images. A
background identification and characterization was performed in
each picture via analysis of pixel intensity distribution. Analysis
of the lowest intensity pixels allowed us to measure the mean low-
est intensity and its corresponding standard deviation in areas
outside the cell. These parameters were used to set a dynamic
threshold and perform background subtraction. Pixels above
threshold were identified as being part of cell material through
automated selection criteria. Total cell area (total number of pix-
els), total cell intensity (sum of the intensity for all pixels above
threshold) and total cell volume (total area times total intensity)
were computed. In order to normalize the signal by the amount of
cell material in each picture (cell size and number of cells), ratios
between total cell intensity and total cell area were calculated and
compared for control and treated samples.
In an additional series of experiments, VSMC were incubated
with Ki16425 (10μM) to determine the effect of LPAR inhibi-
tion on the production of ROS. The Ki16425 inhibitor was added
to the cells 30min before and throughout the exposure to LPA
and DHE. Additional control experiments for this series were
performed in the presence of LPA and DHE without Ki16425.
ISOLATED VESSEL EXPERIMENTS
First-order cremaster arterioles were isolated, cannulated, and
pressurized to monitor vascular diameter changes ex vivo as pre-
viously described (Martinez-Lemus et al., 2011). To this end,
the excised cremaster muscle was pinned flat in a refriger-
ated (4◦C) dissecting chamber and a first-order segment of
the cremaster feed arteriole was isolated. The dissection cham-
ber contained physiological saline solution (PSS) of the follow-
ing composition: 5.0mM dextrose, 3.0mM 3-(N-morpholino)
propane sulfonic acid (MOPS) buffer, 2.0mM pyruvate, 0.02mM
EDTA, 145.0mM NaCl, 4.7mM KCL, 2.0mM CaCl2, 1.2mM
MgSO4, 1.0mM NaH2P04, and 0.15mM bovine serum albu-
min, at pH 7.4. The isolated arterioles were cannulated, without
flow at 60mm Hg in an observation chamber (Living Systems
Instrumentation, Burlington, VE) filled with MOPS-PSS without
albumin. The chamber was mounted on an inverted microscope
(Zeiss Axiovert 40 C). The luminal diameter was monitored with
a video caliper system connected to a video camera and the
changes in the inner diameter were recorded using Lab Chart 7
(ADInstruments, Colorado Springs, CO) as previously described
(Martinez-Lemus, 2008).
To determine the effect of LPA onmyogenic constriction, resis-
tance arteries were exposed for 2 h to LPA (2μM). Control vessels
were exposed to PSS in the absence of LPA. Then arterioles with or
without LPA were exposed to 20mm Hg incremental changes in
intravascular pressure from 40 to 100mm Hg. Exposure to LPA
was maintained during the acquisition of the pressure diameter
curves.
To determine if the effect of LPA on myogenic constriction
occurred via LPA signaling through VSMC membrane bound
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G-protein coupled receptors, LPA receptors (LPAR) were blocked
with 10μM Ki16425. At this concentration, Ki16425 preferen-
tially inhibits LPAR1 and LPAR3-mediated responses and has
moderate inhibitory effects on LPAR2 (Ohta et al., 2003). Ki16425
was added to the vessels 30min before and throughout the expo-
sure of vessels to LPA. In this series of experiments, Ki16425 was
dissolved in methanol. The final concentration of methanol in the
PSS buffer was 0.25% v/v.
To determine how ROS modulate the effects of LPA on
myogenic constriction, pressure-diameter experiments with or
without LPA were performed in the presence of the superox-
ide dismutase mimetic, tempol (Calbiochem, Billerica, MA),
or the cell permeable NADPH oxidase inhibitor, gp91 ds-tat
(Biomatik, Wilmington, DE). In vessels, we decided to use gp91
ds-tat instead of apocynin to inhibit NADPH oxidase produc-
tion of superoxide because in our experience dimethyl sulfoxide
(DMSO), the chemical used to dissolve apocynin, causes ves-
sels to develop vasomotion through an endothelium-dependent
mechanism. This makes it difficult to determine with precision
when a stable diameter is reached after a change in intralumi-
nal pressure. Tempol (250μM) was added to the vessels 30min
before and throughout the 2-hour exposure to LPA, while gp91
ds-tat (50μM) was added 30min before and throughout the first
30min of incubation with LPA. Total incubation time with LPA
was 2 h.
STATISTICAL ANALYSIS
Data are reported as means ± s.e.m. Statistical analysis for all the
AFM and confocal microscopy data was performed using two-
tailed, unpaired Student’s t-test. The slopes of the myogenic con-
striction were analyzed as previously described (Martinez-Lemus
et al., 2005a). Briefly, using linear regression analysis we calculated
the slopes of the changes in diameter induced by the step increases
in pressure. The average slope values were analyzed using two-
tailed unpaired Student’s t-test, for comparisons between two
groups, and One-Way ANOVA followed by Bonferroni correc-
tion for multiple comparisons, for comparisons between multiple
groups. Values refer to the number of cells from each group or
the number of vessels used to calculate mean values. A value of
P < 0.05 was considered statistically significant.
RESULTS
LPA INCREASES INTEGRIN-FN ADHESION
To quantify the cell-bead adhesion, FN-coated beads were applied
to the surface of VSMC. The cells, prior to the experiment, were
incubated for 2 h in the presence or absence LPA (2μM). In con-
trol cells, not exposed to LPA, the number of adhesion events
was 52% lower (P < 0.05) than in LPA treated cells (Figure 1E).
The analysis of the observed binding events, plotted as histograms
of the adhesion forces vs. the corresponding number of adhe-
sion events, revealed that LPA treatment increased the number of
adhesion events without affecting the adhesion force (represented
by the first peak). The most frequently observed adhesion force
was 39 ± 11 pN for control (Figure 1C) and 40 ± 13 pN for LPA
(Figure 1D). LPA also induced a rightward shift in the adhesion
forces resulting in an increase in the number of adhesion events
at higher forces (∼80 pN, Figure 1D).
As integrins containing β1 and β3 subunits are the most com-
mon receptors for FN (Johansson et al., 1997), we determined
the specificity of binding by incubating VSMC with function-
blocking antibodies directed against of β1 and β3integrins.
Incubation of these antibodies with VSMC in the presence of LPA
resulted in a significant 65% decrease in the number of adhesions
per curve compared with cells exposed to LPA alone (P < 0.05,
Figure 1F). In contrast, the presence of an iso-type antibody, as a
control, in cells exposed to LPA did not reduce the integrin-FN
adhesion (Figure 1G). Therefore, the observed adhesion events
appear to represent bonds formed between FN and β1 and β3
containing integrins.
Ki16425 BLOCKS THE LPA-INDUCED INCREASED ADHESION OF VSMC
TO FN
To determine if LPA (2μM) increased integrin-FN adhesion
through its G-protein coupled receptors, experiments were per-
formed in the presence of the LPAR inhibitor Ki16425. Exposure
of VSMC to LPA, in the presence of Ki16425 (10μM), resulted
in a significant 40% decrease in the number of adhesions per
curve compared with the cells treated with LPA alone (P < 0.05,
Figure 2A). Incubation of VSMC with DMSO, the vehicle for
Ki16425, did not significantly affect the adhesion of VSMC to
FN in cells treated with LPA (Figure 2B). Similarly, in VSMC
incubated with Ki16425 alone the integrin-FN adhesion was not
significantly different from untreated control cells (Figure 2C).
TEMPOL OR APOCYNIN REDUCES LPA-INDUCED ADHESION OF VSMC
TO FN
To determine the role of ROS in LPA-induced integrin-FN adhe-
sion, VSMC were incubated with LPA in the presence or absence
of the ROS inhibitors tempol or apocynin. In VSMC exposed
to LPA and tempol (250μM) the binding of integrins to FN
was decreased by 47% below the level of the VSMC treated with
LPA alone (P < 0.05, Figure 3A). Furthermore, VSMC exposed
to LPA and apocynin (300μM) also showed a 59% decrease
in integrin-FN adhesion compared with VSMC treated with
LPA alone (P < 0.05, Figure 3B). VSMC incubated 2 h with
either tempol or apocynin alone had no significantly changes in
integrin-FN adhesion compared to control cells not exposed to
LPA (data not shown).
LPA INCREASES ROS PRODUCTION BY VSMC THROUGH A
MECHANISM INVOLVING LPAR1 AND LPAR3
To confirm that the increase in the production of ROS was
induced by LPA, VSMC were incubated in serum free media
with LPA and DHE, a superoxide specific fluorescent detector.
In control VSMC exposed to DHE (10μM) alone, after 2 h of
treatment, the fluorescent intensity was 45% below the level of
the VSMC incubated 2 h with LPA (2μM) and DHE (10μM)
(P < 0.05, Figures 4A,B). Furthermore, to determine that the
signaling pathway responsible for the ROS production increase
involved the surface receptors LPAR1 and LPAR3, experiments
were performed in the presence or absence of Ki16425. In VSMC
incubated 2 h with LPA (2μM) and DHE (10μM), in the pres-
ence of Ki16425 (10μM), the ROS-associated florescence inten-
sity decreased by 45% (P < 0.05, Figures 4C,D), significantly
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FIGURE 2 | LPA-induced FN-integrin adhesion is decreased by blockade
of LPA receptors LPAR1 and LPAR3. (A) LPA treatment (2μM) for 2 h in
the presence of Ki16425 (10μM, n = 40) results in a 40% decrease in
FN-integrin adhesion compared with the cells treated with LPA alone
(n = 40). (B) Incubation of VSMC with LPA (2μM) in the presence of
DMSO (n = 39), the solvent for Ki16425, does not result in a change in
FN-integrin adhesion compared with VSMC treated with LPA (2μM) alone
(n = 39). (C) Ki16425 (10μM, n = 40) alone does not change significantly
the integrin-FN adhesion of VSMC compared with untreated controls
(n = 40). Data are mean ± s.e.m. ∗P < 0.05 vs. LPA alone.
FIGURE 3 | ROS inhibition abolishes the LPA-induced increase in
FN-integrin binding. (A) Incubation of VSMC with LPA (2μM) for 2 h in the
presence of tempol (250μM, n = 36) results in a 47% decrease in
FN-integrin adhesion compared with LPA alone (n = 35). (B) Compared
with LPA alone (n = 40), 2 h of LPA (2μM) treatment, in the presence of
apocynin (300μM, n = 39), reduced FN-integrin adhesion by 59%. Data are
means ± s.e.m. ∗P < 0.05 vs. LPA alone.
below the fluorescence levels of VSMC exposed for the same
amount of time only to LPA (2μM) and DHE (10μM), for 2 h
(Figure 4D).
LPA ENHANCES MYOGENIC CONSTRICTION OF ISOLATED RESISTANCE
ARTERIES
Exposure of cremasteric arterioles, for 2 h, to LPA (2μM)
caused a significant enhancement of the myogenic constric-
tion induced by consecutive increments in intraluminal pressure
compared with that of control vessels incubated with vehi-
cle alone (Figure 5A). The slope analysis of the pressure vs.
diameter regression line revealed that LPA caused a significant
71% increase in myogenic constriction compared with controls
(LPA = −0.48 ± 0.04 vs. control = −0.28 ± 0.06, P < 0.05,
Figure 5B).
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FIGURE 4 | LPA-induced ROS production is inhibited by blockade of
LPAR1 and LPAR3. (A) Representative images of DHE-dependent
fluorescence in VSMC exposed to 2μM LPA (left) or vehicle control
(right) for 2 h. (B) In VSMC exposed for 2 h to DHE (10μM, n = 5)
alone the fluorescence intensity is 45% lower than in VSMC incubated
2 h with LPA + DHE (n = 5). (C) Representative images of
DHE-dependent fluorescence in VSMC exposed LPA alone (left) or
LPA + Ki16425 (right). (D) VSMC exposure to both Ki16425 (10μM,
n = 5) and LPA reduced the increase in fluorescence induced by LPA
alone by 45% (n = 5). Data were normalized to the average intensity
values of LPA treatment. Bar size = 20μm. Data are means ± s.e.m.
∗P < 0.05 vs. LPA + DHE.
KI16425 AND THE BLOCKADE OF ROS PRODUCTION BLUNTS THE
LPA-INDUCED ENHANCEMENT IN MYOGENIC CONSTRICTION
To determine how LPA was enhancing the myogenic constric-
tion, isolated arterioles were incubated for 2 h with LPA (2μM)
in the presence of the LPAR1, LPAR3 inhibitor Ki16425 (10μM),
the superoxide dismutase mimetic tempol (250μM) and the
inhibitor of NADPH oxidase, gp91 ds-tat (50μM). The slope
analysis of the pressure vs. diameter regression line revealed that
vessels exposed to LPA in the presence of Ki16425 exhibited
a significant 58% decrease in myogenic constriction compared
with vessels treated with LPA alone (LPA + Ki16425 = −0.2 ±
0.09 vs. LPA = −0.48 ± 0.04, P < 0.05, Figure 5C). Similarly,
tempol decreased the myogenic constriction induced by LPA by
56%, significantly different from the vessels exposed to LPA alone
(LPA + tempol = −0.22 ± 0.1 vs. LPA = −0.48 ± 0.04, P <
0.05, Figure 5C). Vessels exposed to LPA in the presence of gp91
ds-tat also exhibited a significantly reduced myogenic constric-
tion, by 55%, compared with resistance arteries exposed to LPA
alone (LPA + gp91 ds-tat = −0.21 ± 0.09 vs. LPA = −0.48 ±
0.04, P < 0.05, Figure 5C). There were no significant differences
in the slopes of themyogenic constriction between control vessels,
not exposed to LPA, and the vessels treated with LPA + Ki16425,
LPA + tempol, and LPA + gp91 ds-tat (Figure 5D). Methanol
(0.25% v/v), the solvent for Ki16425, did not significantly change
the slope of the myogenic constriction compared with control
vessel (methanol = −0.34 ± 0.04 vs. control = −0.28 ± 0.06,
Figure 5D).
DISCUSSION
The principal finding of this study is that in rat VSMC the
LPA-induced increase in integrin-FN adhesion is dependent on
the release of ROS. Based on previous publications indicating
that LPA modulates integrin-ECM binding (Sun et al., 2005;
Eriksson et al., 2006; Valenick and Schwarzbauer, 2006) and trig-
gers integrin mediated intracellular signaling (Tatler et al., 2011)
in cultured cells, we first performed a series of AFM experi-
ments to determine the effects of 2 h of exposure to LPA (2μM)
on the VSMC adhesion to FN. LPA caused a doubling in the
number of adhesion events between cells and the FN coated
bead. The LPA-induced rise in adhesive events was blocked by
the simultaneous incubation with antibodies directed against β1
and β3 integrins. These results indicate that the LPA-induced
adhesion increase is mediated by integrins containing β1 and β3
subunits. Indeed, integrins containing these β subunits are spe-
cific cell surface receptors for FN (Charo et al., 1990; Wu et al.,
1993).
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FIGURE 5 | LPA-induced enhancement of myogenic constriction is
blocked by Ki16425, tempol and gp91 ds-tat. (A) For the same step
increases in intraluminal pressure, vessels exposed to LPA (2μM) for 2 h
(n = 14) constrict more than control arterioles (n = 12). Variations in diameter
are expressed as a percent of the vascular diameter attained at 40mm Hg.
(B) Slope analysis of the myogenic constriction, determined by the
regression analysis of the diameter changes induced by the step increases in
intraluminal pressure, reveals that the LPA treated vessels constrict 71%
more than controls. (C) Slope analysis reveals that Ki16425 (n = 9), tempol
(n = 9), and gp91 ds-tat (n = 9) significantly reduce the myogenic constriction
enhancement induced by LPA. (D) Slope analysis of the myogenic
constriction reveals that Ki16425 (n = 9), tempol (n = 9), and gp91 ds-tat
(n = 9) reduce the myogenic constriction induced by LPA to control levels.
Methanol alone (n = 8), the solvent for Ki16425, does not significantly affect
the myogenic constriction of resistance arteries. Data are means ± s.e.m.
∗P < 0.05 vs. LPA (B,C).
LPA is produced by a number of cell types such as fibroblasts,
platelets (Pagès et al., 2001), and also by ovarian cancer cells (Pua
et al., 2009). In physiological conditions the plasma concentra-
tion of LPA varies between 0.1μM and 1μM, whereas serum
concentrations can sometimes exceed 10μM (Lin et al., 2010). In
pathological conditions the serum LPA concentration can go up
to 20μM (Swarthout and Walling, 2000). Therefore, the concen-
tration of LPA used in this study is within physiological range.
LPA appears to function as a pathophysiological modulator in
cells of the cardiovascular system by regulating important cellular
functions, such as VSMC contraction, stimulation of VSMC pro-
liferation, modulation of endothelial barrier function and platelet
aggregation (Smyth et al., 2008). Indeed, exogenous LPA, in rats,
elevates arterial blood pressure (Tokumura et al., 1978), while
topical application in pigs causes vasoconstriction of cerebral
arteries (Tigyi et al., 1995). The finding that LPA induces inti-
mal hyperplasia in conduit arteries (Yoshida et al., 2003) suggests
that LPA is involved in VSMC migration and proliferation, pro-
cesses that are associated with integrin activity andmodulation, as
well as with ROS production (Gerthoffer, 2007). LPA-stimulated
cell migration and proliferation appears to be dependent on the
activation of the G-protein coupled receptors LPAR1, LPAR2, and
LPAR3 (Kim et al., 2006; Panchatcharam et al., 2008). These find-
ings suggest that LPA signaling through LPAR1-3might modulate
integrin activity, as an increased turnover of focal adhesions is
required for enhanced VSMC migration. Thus, our results show-
ing that LPA increases integrin-FN binding in VSMC indicates
that LPAR might modulate the process of integrin-FN adhesion.
To determine the role of LPA signaling through its cell surface
receptors, we exposed VSMC to LPA in the presence of Ki16425,
a specific inhibitor of LPAR1-3 (Ohta et al., 2003). Although,
Ki16425 also moderately inhibits LPAR2 receptor (Ki = 6.5μM),
the contribution of this receptor to the LPA-mediated integrin
activation, in rat VSMC, is unlikely because of recent studies
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showing that LPAR2 is not present on the surface of rat VSMC
(Subramanian et al., 2010; Zhou et al., 2010). Ki16425 is a short
lived reversible antagonist of LPAR1 and LPAR3 (Ma et al., 2009),
therefore, to insure continual inhibition of LPAR, the concentra-
tion of Ki16425 used in our study was one order of magnitude
higher than the Ki = 0.93μM necessary to inhibit LPAR3 sig-
naling. At the concentration of 10μM, Ki16425 has been shown
to significantly inhibit LPA-induced cell migration (Kim et al.,
2008). Our data showed that Ki16425 (10μM) induced a 40%
decrease in integrin-FN adhesion suggesting that LPA-induced
increase in integrin-FN adhesion is mediated through a mecha-
nism involving LPAR1 and LPAR3. The decrease in LPA-induced
integrin-FN adhesion is comparable to the adhesion levels found
in control VSMC, unexposed to LPA. As Ki16425 alone does
not change the adhesion of VSMC, our results indicate that the
LPA-induced adhesion increase is almost completely blocked by
Ki16425.
As mentioned above, LPA-induced SMC growth results in
the production ROS, through Rac dependent signaling (Schmitz
et al., 2002; Kaneyuki et al., 2007). Also, ROS are important mod-
ulators of integrin function (Gregg et al., 2004; Begonja et al.,
2005). Cumulatively, the evidence from those studies together
with our results, showing that LPA increases integrin binding
activity, suggests that LPA might induce increased production
of ROS leading to integrin activation. Therefore, to determine
whether the increase in integrin-FN adhesion, induced by LPA,
is modulated through ROS dependent signaling, we performed
experiments in the presence of tempol (250μM), a superoxide
dismutase mimetic, and apocynin (300μM). We have previ-
ously shown that tempol and apocynin at these concentrations
are effective scavengers of superoxide (Martinez-Lemus et al.,
2011). Our results showed that tempol blunted the LPA-induced
integrin-FN adhesion increase, suggesting that production of
superoxide anion is associated with the increase in integrin adhe-
sion.Moreover, the incubation of VSMCwith LPA in the presence
of apocynin also resulted in decreased integrin-FN adhesion. Our
results, obtained in VSMC incubated 2 h with LPA in the presence
of DHE (a superoxide specific florescent dye) confirmed that LPA
(2μM) increased the production of superoxide. The increase in
superoxide production, induced by LPA, was almost completely
inhibited by the blockade of LPAR1 and LPAR3 with Ki16425.
Overall, these results suggest that, in our experimental conditions,
LPA signaling through LPAR1 and LPAR3 induces an enhanced
production of superoxide, which modulates, in part, the increase
in VSMC integrin adhesion to FN.
Integrins, by linking the ECM and cellular cytoskeleton, have
been extensively studied as bi-directional transducers of mechan-
ical and chemical signals across the cell membrane (Hu and Luo,
2013). In this context, integrins have been shown to be important
components in the mechanisms responsible for the acute con-
trol of vascular diameter by directly modulating the myogenic
tone and constriction of isolated resistance arteries (Martinez-
Lemus et al., 2005a). In these vessels, myogenic constriction,
characterized by vasoconstriction in response to pressure eleva-
tion, is believed to significantly contribute to the autoregulation
of blood flow in order to sustain physiological tissue perfusion.
The myogenic constriction is altered in pathological conditions
such as, hypertension and diabetes (Falcone et al., 1993; Hill and
Meininger, 1993). Based on our current data and previous results
(Martinez-Lemus et al., 2005a), changes in integrin-ECM adhe-
sions should result in an altered myogenic constriction to intra-
luminal pressure step increases. Therefore, to determine whether
LPA altered myogenic constriction, we performed experiments in
isolated cremasteric arterioles in the presence of LPA. Our results
indicate that LPA enhances myogenic constriction. These results
suggest that integrin activation and/or ROS may be responsible,
in part, for the observed increase in constriction. This is con-
sistent with previous data showing that integrins are important
components in the mechanisms involved in myogenic constric-
tion (Martinez-Lemus et al., 2005a). However, the direct effects of
integrin blockade in the presence of LPA cannot be easily tested,
as blockade of β1 and β3 integrins with specific antibodies blunts
myogenic constriction (Martinez-Lemus et al., 2005a). Therefore,
we performed experiments to determine the effects of LPA, on
myogenic constriction, in the presence of Ki16425 (10μM), tem-
pol (250μM) and gp91 ds-tat (50μM). By testing the involve-
ment of LPAR1/LPAR3 and superoxide onmyogenic constriction,
in vessels exposed to LPA, we would indirectly evoke our findings
from VSMC, where blockade of LPA signaling and ROS scaveng-
ing reduced integrin activation. We expected that by blocking
the mechanisms of LPA-induced integrin activation we would
observe a reduction in the LPA-enhanced myogenic constriction.
Our results confirm that indeed, the blockade of LPA signaling
through LPAR1 and LPAR3, with Ki16425, reduced the slope of
myogenic constriction to control levels. Additionally, superoxide
scavenging with tempol also resulted in a reduction in myogenic
constriction, similar to control levels. Further inhibition of ROS
release from NADPH oxidase with apocynin was not performed,
as the role of apocynin as a specific inhibitor of NADPH oxi-
dase has been challenged. A couple of studies suggest that in
VSMC apocynin predominantly acts as an antioxidant to reduce
ROS (Heumuller et al., 2008; Schlüter et al., 2008). Therefore,
to test the specific involvement of NADPH oxidase and the pro-
duction of superoxide in the LPA-induced increase in myogenic
constriction, we used the NADPH oxidase inhibitor gp91 ds-tat.
We found that blockade of NADPH oxidase activity with gp91
ds-tat reduced the LPA-induced increase in myogenic constric-
tion to control levels as tempol did. These data are consistent with
previous work showing that ROS production increases myogenic
constriction (Ren et al., 2010). Our results, from resistance vessels,
indicate that LPA is inducing an increased myogenic constriction
thoughmechanisms that include LPAR1 and LPAR3, as well as the
generation of superoxide anion. These results corroborate those
obtained in isolated VSMC and suggest that LPA, through its
LPAR1 and LPAR3, increases NADPH oxidase-dependent super-
oxide production. Although it could be argued that the effects
of tempol acting as a SOD mimetic should increase production
of H2O2, tempol is known to possess catalase-like actions that
rapidly convert H2O2 into water (Wilcox and Pearlman, 2008).
In this study we did not measure the amount of H2O2 produced
by cells or vessels in the presence of tempol, but our results using
the specific NADPH oxidase inhibitor gp91 ds-tat strongly sug-
gest that it is indeed superoxide the main ROS responsible for
modulating the myogenic response. The release of ROS, in turn,
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results in the activation of integrins and promotes integrin-ECM
adhesions. Therefore, LPA, by increasing integrin-FN adhesion,
appears to modulate myogenic constriction in resistance vessels.
Our findings clearly identify ROS as modulators of VSMC
integrin activity and the myogenic response. This knowledge
increases our understanding of the process of mechanotrans-
duction that occurs at the level of VSMC in resistance arteries
and their response to changes in intraluminal pressure. However,
a number of questions on the identity of the mechanosensors
responsible for detecting changes in intraluminal pressure and
the sequence of events that ultimately change the level of VSMC
contraction and vascular diameter remain to be fully elucidated.
We have previously shown that blockade of αvβ3 and α5β1 inte-
grins inhibits myogenic vasoconstriction in resistance vessels
and have speculated on their potential role as mechanosensors
(Martinez-Lemus et al., 2003, 2005a,b). A recent study, however,
clearly indicates that the angiotensin-II type 1a (AT-1) receptor
is mechanosensitive and that its absence dampens the myogenic
response in resistance arteries (Schleifenbaum et al., 2014). As
stimulation of the AT-1 receptor is known to induce ROS pro-
duction, it could be speculated that stretch sensitive G-protein
coupled receptors may be the mechanosensors responsible for
inducing the production of ROS that subsequently activates inte-
grins in the myogenic response. In this scenario, the role of
ROS-dependent integrin activation could be associated with: (1)
an increase in cell adhesion as reported in the present study, (2)
the strengthening of actin cytoskeletal structures as it has been
reported occurs in VSMC following angiotensin-II stimulation
(Hong et al., 2014), and (3) actin polymerization as it has been
shown occurs during myogenic vasoconstriction (Cipolla et al.,
2002; Flavahan et al., 2005). In addition, the specific sources of
ROS also remain to be clearly identified. Our present results sug-
gest that the main source is NADPH oxidase. However, a recent
study suggests that mitochondrial superoxide and H2O2 may
also be involved in the myogenic process (Gebremedhin et al.,
2013). If that is the case, the mechanisms by which mitochon-
dria are induced to produce ROS in response to increments in
vascular intraluminal pressure would need to be elucidated. Our
current findings also relate to previous reports indicating that
integrins and ROS are involved in the phenotypic changes expe-
rienced by VSMC in different pathological circumstances such
as, hypertension and atherosclerosis. In the microcirculation, we
have recently shown that the inward remodeling of resistance
arteries, commonly encountered in essential hypertension is asso-
ciated with the repositioning of VSMC and the production of ROS
(Martinez-Lemus et al., 2004, 2011). We also found that inhibi-
tion of the small GTPase Rac1, a component of the active NADPH
oxidase, blocks the development of this specific type of remodel-
ing (Staiculescu et al., 2013). Additionally, in the small arteries of
(mRen2) 27 rats, inward eutrophic remodeling is dependent on
the activity of αVβ3 integrins (Heerkens et al., 2006). Moreover,
the vascular remodeling triggered by infusion of LPA is associ-
ated with VSMC proliferation andmigration (Cheng et al., 2009),
and integrins modulate some of these adaptive changes. Indeed,
α5β1 integrins control in part the migration and proliferation of
VSMC within the atherosclerotic plaque (Barillari et al., 2001).
Cumulatively, those studies and our results are consistent with
current evidence indicating that ROS and LPA modulate cellular
signaling pathways that induce both acute and chronic changes in
VSMC behavior via integrins. Our experiments, in isolated arteri-
oles, also suggest that LPA might play a role in the modulation of
vasomotor behavior through a mechanism involving the release
of ROS and integrin activation. A better understanding of the
integrin modulation by LPA through ROS dependent pathways
should provide new therapeutic approaches for controlling the
adverse cardiovascular events associated with atherosclerosis and
hypertension.
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